课题基金 / 基金详情

T CELL ACTIVATION IN HIV 1 REVERSE TRANSCRIPTION/INTEGRA

T CELL ACTIVATION IN HIV 1 REVERSE TRANSCRIPTION/INTEGRA
HIV 1 逆转录/整合中的 T 细胞激活
批准号:
2887027
负责人:
LINDA B LUDWIG
金额:
$12.62万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-15 至 2001-06-30

项目摘要

项目成果

LINDA B LUDWIG的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(改编自研究者摘要)在本提案中,a
英文摘要
DESCRIPTION: (Adapted from investigator's abstract) In this proposal, a young investigator wishes to study if proteins involved in T cell activation might be used in the HIV-1 reverse transcription. To facilitate her studies, she has obtained preliminary data demonstrating that T cell proteins bind to biotinylated HIV-1 single stranded DNA and RNA constructs using a non-radioactive adaptation of the electrophoretic mobility shift assay. Using this technique, the investigator proposes to investigate the interaction of HIV-1 reverse transcription intermediates with T cell proteins to test the hypothesis that early and efficient reverse transcription of HIV-1 ssDNA intermediates may assist HIV-1 in the infection process by providing a binding site for host cell proteins involved in pre-integration or integration events. Towards this goal, the investigator proposes the following Specific Aims: Specific Aim 1: To delineate the specific sites on HIV-1 RNA, single stranded DNA, RNA DNA hybrid constructs interacting with T cell proteins. Specific Aim 2: To investigate interactions between HIV-1 reverse transcription intermediates and the HIV-1 integrase protein
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Retroviral Antisense Genes as Future DNA Vaccines.
HIV CHEMOKINE-LIKE PROTEINS
T CELL ACTIVATION IN HIV 1 REVERSE TRANSCRIPTION/INTEGRA
T CELL ACTIVATION IN HIV 1 REVERSE TRANSCRIPTION/INTEGRA
海外基金